Sanofi-Synthelabo (India) Profile
Key Indicators
- Authorised Capital ₹ 43.15 Cr
as on 14-05-2024
- Paid Up Capital ₹ 33.41 Cr
as on 14-05-2024
- Company Age 22 Year, 1 Month
- Last Filing with ROC 31 Mar 2020
- Revenue 16.11%
(FY 2020)
- Profit 91.63%
(FY 2020)
- Ebitda 60.32%
(FY 2020)
- Net Worth 16.55%
(FY 2020)
- Total Assets 15.10%
(FY 2020)
About Sanofi-Synthelabo (India)
- CIN/LLPIN
U24230MH2002PTC137682
- Company No.
137682
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Oct 2002
- Date of AGM
27 Nov 2020
- Date of Balance Sheet
31 Mar 2020
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Sanofi-Synthelabo (India)?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Deepa Shah  | Company Secretary | 30-Mar-2017 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vaibhav Karandikar | Additional Director | 02-Feb-2021 | Current |
| Rajaram Narayanan | Director | 01-Jan-2018 | Current |
| Praveen Khullar | Director | 14-Dec-2018 | Current |
Financial Performance and Corporate Structure Insights of Sanofi-Synthelabo (India).
Sanofi-Synthelabo (India) Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 16.11% increase. The company also saw a substantial improvement in profitability, with a 91.63% increase in profit. The company's net worth Soared by an impressive increase of 16.55%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sanofi-Synthelabo (India)?
In 2020, Sanofi-Synthelabo (India) had a promoter holding of 100.00%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Vergo Pharma Research Laboratories Private LimitedActive 14 years 4 months
Praveen Khullar is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sanofi-Synthelabo (India)?
Sanofi-Synthelabo (India) has a workforce of 332 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sanofi-Synthelabo (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sanofi-Synthelabo (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
